Small Pharma to start world’s first clinical trial of DMT-assisted depression treatment

UK neuro-pharmaceutical company Small Pharma said that they have gained regulatory approval in early December 2020 to launch the world’s first patient clinical trials using dimethyltryptamine (DMT) to potentially treat depression and isolate the root cause of the ailment, Pharmafield reported.  The company is set to start the initial trial for this month, after receiving […]